Back

Supervised non-negative matrix factorization on cell-free DNA fragmentomic features enhances early cancer detection

Tran, T. H.; Pham, N. T.; Nguyen, V. T. C.; Vo, D. H.; Nguyen, T. H. H.; Tran, T. T.; Tran, T. T.; Vo, T. D. H.; Dao, T. H.; Nguyen, H. T. P.; Phan, T. V.; Ha, T. M. T.; Ngo, T. D. H.; Tran, N.-H.; Tran, N.-T.; Hoang, T. Q.; Nguyen, V. B.; Le, V. C.; Nguyen, X. C.; Nguyen, T. M. P.; Nguyen, V. H.; Tran, N. T. N.; Dang, T. N. Q.; Tran, M. H.; Nguyen, P. N.; Pham, T. A. T.; Vo, D. L.; Doan, T. N.; Nguyen, V. H.; Tran, Q. D.; Dang, Q. T.; Ho, L. M. Q.; Nguyen, V. T. A.; Nguyen, S. T.; Nguyen, H.-N.; Tran, L. S.; Giang, H.; Phan, M. D.; Nguyen, T. H.

2024-12-20 bioinformatics
10.1101/2024.12.20.629316 bioRxiv
Show abstract

BackgroundCell-free circulating DNA (cfDNA) fragments exhibit non-random patterns in their length (FLEN), end-motif (EM), and distance to nucleosome position (ND). While these cfDNA features have shown promise as inputs for machine learning and deep learning models in early cancer detection, most studies utilize them as raw inputs, overlooking the potential benefits of pre-processing to extract cancer-specific features. This study aims to enhance cancer detection accuracy by developing a novel approach to feature extraction from cfDNA fragmentomics. MethodsWe implemented a supervised non-negative matrix factorization (SNMF) algorithm to generate embedding vectors capturing cancer-specific signals within cfDNA fragmentomic features. These embeddings served as input for a machine learning model to classify cancer patients from healthy individuals. ResultsWe validated our framework using two datasets: an in-house cohort of 431 cancer patients and 442 healthy individuals (dataset 1), and a published cohort comprising 90 hepatocellular carcinoma (HCC) patients and 103 individuals with cirrhosis or hepatitis B (dataset 2). In dataset 1, we achieved an AUC of 94% in pan-cancer detection. In dataset 2, our framework achieved an AUC of 100% for HCC vs healthy classification, 99% for HCC vs non-HCC patients classification, and 96% for identifying HCC patients among a mixed group of non-HCC patients and healthy donors. ConclusionThis study demonstrates the efficiency of SNMF-transformed features in improving both pan-cancer detection and specific HCC detection. Our approach offers a significant advancement in leveraging cfDNA fragmentomics for early cancer detection, potentially enhancing diagnostic accuracy in clinical settings.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.